A SECRET WEAPON FOR MBL77

Not all people with CLL call for therapy. In spite of all latest developments, the iwCLL however suggests watchful observation for patients with asymptomatic ailment.86 This recommendation is predicated on at least two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).